Vir Biotechnology Inc (VIR) — Capital Reinvestment Ratio
Vir Biotechnology Inc (VIR) has a Capital Reinvestment Ratio of 0.36x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.13 Million) in capital expenditures ($12.60 Million). Check Vir Biotechnology Inc (VIR) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vir Biotechnology Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Vir Biotechnology Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Vir Biotechnology Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for Vir Biotechnology Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Vir Biotechnology Inc from 2022 to 2022. See VIR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $1.66 Billion | $68.01 Million | — |